Bone Biologics Corp (BBLGW) Profit After Tax (2010 - 2025)

Bone Biologics (BBLGW) has reported Profit After Tax for 16 consecutive years, with -$684643.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Profit After Tax rose 55.01% year-over-year to -$684643.0; the TTM figure through Dec 2025 stood at -$3.1 million (up 24.4% YoY), while the FY2025 annual figure was -$3.1 million, up 24.4% from the prior year.
• Profit After Tax fell to -$684643.0 in Q4 2025 per BBLGW's latest filing, from -$666737.0 in the prior quarter.
• Across five years, Profit After Tax topped out at $893460.0 in Q4 2022 and bottomed at -$3.7 million in Q1 2023.
• Historically, Profit After Tax has averaged -$963272.4 across 5 years, with a median of -$762126.0 in 2024.
• Annual changes were most pronounced in 2022 — Profit After Tax jumped 602.69% — and 2023, when it slumped 438.06%.
• Bone Biologics' Profit After Tax stood at -$177737.0 in 2021, then surged by 602.69% to $893460.0 in 2022, then slumped by 273.47% to -$1.5 million in 2023, then grew by 1.82% to -$1.5 million in 2024, then soared by 55.01% to -$684643.0 in 2025.
• Business Quant data shows BBLGW's Profit After Tax at -$684643.0 in Q4 2025, -$666737.0 in Q3 2025, and -$740519.0 in Q2 2025.